Showing results (361-370 of 404) with videos related to

Sort By:
Pageof 41
Acta Crystallographica. Section D, Structural Biology|August 5, 2016
Fixed target combined with spectral mapping: approaching 100% hit rates for serial crystallographySaeed Oghbaey, Antoine Sarracini, Helen M Ginn, et al.
Nature Communications|June 7, 2023
Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapyManon Ragonnet-Cronin, Rungtiwa Nutalai, Jiandong Huo, et al.
Journal of Structural Biology|March 9, 2011
Expression of protein complexes using multiple Escherichia coli protein co-expression systems: a benchmarking studyDidier Busso, Yoav Peleg, Tatjana Heidebrecht, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 10, 2021
Quantitative SARS-CoV-2 anti-spike responses to Pfizer-BioNTech and Oxford-AstraZeneca vaccines by previous infection statusDavid W Eyre, Sheila F Lumley, Jia Wei, et al.
Journal of Medicinal Chemistry|November 13, 2004
Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 2George A Freeman, C Webster Andrews Iii, Andrew L Hopkins, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Site-specific steric control of SARS-CoV-2 spike glycosylationJoel D Allen, Himanshi Chawla, Firdaus Samsudin, et al.
Cell Host & Microbe|June 26, 2020
Neutralization of SARS-CoV-2 by Destruction of the Prefusion SpikeJiandong Huo, Yuguang Zhao, Jingshan Ren, et al.
Biochemistry|July 2, 2021
Site-Specific Steric Control of SARS-CoV-2 Spike GlycosylationJoel D Allen, Himanshi Chawla, Firdaus Samsudin, et al.
Antiviral Research|December 1, 2009
Structure and functionality in flavivirus NS-proteins: perspectives for drug designMichela Bollati, Karin Alvarez, René Assenberg, et al.
Pageof 41